PBLS
Parabilis Medicines, Inc.
There isn't enough reported data to score PBLS yet.
PBLS Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Unavailable | |
| Unavailable | |
| Unavailable |
There isn't enough reported data to rate PBLS's fundamentals.
PBLS PE Valuation
PBLS has no meaningful PE right now: it lost money over the past year.
PBLS Forward outlook
There aren't enough analyst estimates for PBLS to show an outlook.
PBLS Earnings Per Share
PBLS Quarterly Revenue
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -2589% | N/A |
| Q2 2026 | -34382% | N/A |
PBLS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q1 2026 | -$49.6M | -$15.3M |
PBLS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +328% | +94.7M shares |
| Quarter | Spent |
|---|---|
| Q1 2026 | — |
| Q2 2025 | — |
| Q1 2025 | — |
PBLS Net Leverage
PBLS's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
PBLS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 39.6 | Neutral |
| Stochastic | 27.8 | Neutral |
PBLS's weekly RSI is 40 (neutral) and its Stochastic is 28 (neutral).
PBLS PE vs Healthcare Sector
PBLS has no meaningful PE right now: it lost money over the past year.
PBLS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $27.6 | 0.4% above |
| 20 week MA | $32.3 | 14% below |
PBLS has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 14% below its 20-week average.
PBLS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2026 YTD | $27.3 | $27.7 | +1.6% |
It's up 1.6% so far in 2026.